Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study

Autor: Prescott, Eva, Angerås, Oskar, Erlinge, David, Grove, Erik L., Hedman, Marja, Jensen, Lisette O., Pernow, John, Saraste, Antti, Åkerblom, Axel, Svedlund, Sara, Rudvik, Anna, Knöchel, Jane, Lindstedt, Eva-Lotte, Garkaviy, Pavlo, Gan, Li-Ming, Gabrielsen, Anders
Zdroj: In International Journal of Cardiology 15 October 2022 365:34-40
Databáze: ScienceDirect
Externí odkaz: